Disappointing news.
I just read on face book that CDK inhibitor Ribociclib has been rejected for listing on the PBS. This is very very disappointing news when we have metastatic breast cancer and are always hoping that ...
Forum Discussion
Yes I agree that it seems bias. As most of us have started treatment as soon as possible. I have been on treatment for over 5 years, so I wouldn't qualify. I have been reasonablely well but treatments dont last and we need new treatment that we can afford. I am happy for the girls that make it for a trial drug , but what happens when the trial is finished? Can they afford the treatment if it is not on the PBS .?